Literature DB >> 15778743

CB1 cannabinoid receptor-mediated modulation of food intake in mice.

Jenny L Wiley1, James J Burston, Darnica C Leggett, Olga O Alekseeva, Raj K Razdan, Anu Mahadevan, Billy R Martin.   

Abstract

1 Marijuana's appetite-increasing effects have long been known. Recent research suggests that the CB(1) cannabinoid receptor antagonist SR141716A may suppress appetite. This study represents a further, systematic investigation of the role of CB(1) cannabinoid receptors in the pharmacological effects of cannabinoids on food intake. 2 Mice were food-restricted for 24 h and then allowed access to their regular rodent chow for 1 h. Whereas the CB(1) antagonist SR141716A dose-dependently decreased food consumption at doses that did not affect motor activity, Delta(9)-tetrahydrocannabinol (Delta(9)-THC) increased food consumption at doses that had no effect on motor activity. O-3259 and O-3257, structural analogs of SR141716A, produced effects similar to those of the parent compound. 3 Amphetamine (a known anorectic) and diazepam (a benzodiazepine and CNS depressant) decreased food consumption, but only at doses that also increased or decreased motor activity, respectively. The CB(2) cannabinoid receptor antagonist SR144528 and the nonpsychoactive cannabinoid cannabidiol did not affect food intake nor activity. 4 SR141716A decreased feeding in wild-type mice, but lacked pharmacological activity in CB(1) knockout mice; however, basal food intake was lower in CB(1) knockout mice. Amphetamine decreased feeding in both mouse genotypes. 5 These results suggest that SR141716A may affect the actions of endogenous cannabinoids in regulating appetite or that it may have effects of its own aside from antagonism of cannabinoid effects (e.g., decreased feeding behavior and locomotor stimulation). In either case, these results strongly suggest that CB(1) receptors may play a role in regulation of feeding behavior.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778743      PMCID: PMC1576140          DOI: 10.1038/sj.bjp.0706157

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Medicinal use of cannabis: history and current status.

Authors:  H Kalant
Journal:  Pain Res Manag       Date:  2001       Impact factor: 3.037

Review 2.  Pharmacotherapy of obesity: targets and perspectives.

Authors:  M Chiesi; C Huppertz; K G Hofbauer
Journal:  Trends Pharmacol Sci       Date:  2001-05       Impact factor: 14.819

3.  A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

Authors:  Raquel Gómez; Miguel Navarro; Belén Ferrer; José M Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

4.  Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.

Authors:  C M Williams; T C Kirkham
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

5.  Leptin-regulated endocannabinoids are involved in maintaining food intake.

Authors:  V Di Marzo; S K Goparaju; L Wang; J Liu; S Bátkai; Z Járai; F Fezza; G I Miura; R D Palmiter; T Sugiura; G Kunos
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

6.  Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.

Authors:  N E Rowland; M Mukherjee; K Robertson
Journal:  Psychopharmacology (Berl)       Date:  2001-10-02       Impact factor: 4.530

7.  Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Authors:  Aminah Jatoi; Harold E Windschitl; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; James A Mailliard; Sarode Pundaleeka; Carl G Kardinal; Tom R Fitch; James E Krook; Paul J Novotny; Brad Christensen
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

8.  Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.

Authors:  E Fride; Y Ginzburg; A Breuer; T Bisogno; V Di Marzo; R Mechoulam
Journal:  Eur J Pharmacol       Date:  2001-05-11       Impact factor: 4.432

9.  Observational analysis of feeding induced by Delta9-THC and anandamide.

Authors:  Claire M Williams; Tim C Kirkham
Journal:  Physiol Behav       Date:  2002-06-01

10.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

View more
  73 in total

Review 1.  The endocannabinoid system: role in energy regulation.

Authors:  Thomas F Gamage; Aron H Lichtman
Journal:  Pediatr Blood Cancer       Date:  2012-01       Impact factor: 3.167

Review 2.  Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's Disease.

Authors:  Celina S Liu; Sarah A Chau; Myuri Ruthirakuhan; Krista L Lanctôt; Nathan Herrmann
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

3.  The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.

Authors:  Kelly S Sink; Peter J McLaughlin; Jodi Anne T Wood; Cara Brown; Pusheng Fan; V Kiran Vemuri; Yan Peng; Yan Pang; Teresa Olszewska; Teresa Olzewska; Ganesh A Thakur; Alex Makriyannis; Linda A Parker; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

Review 4.  Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.

Authors:  John D Salamone; Peter J McLaughlin; Kelly Sink; Alexandros Makriyannis; Linda A Parker
Journal:  Physiol Behav       Date:  2007-04-14

Review 5.  Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model.

Authors:  Francesca Oltrabella; Adam Melgoza; Brian Nguyen; Su Guo
Journal:  Dev Growth Differ       Date:  2017-05-17       Impact factor: 2.053

6.  Evaluation of sex differences in cannabinoid dependence.

Authors:  Julie A Marusich; Timothy W Lefever; Kateland R Antonazzo; Rebecca M Craft; Jenny L Wiley
Journal:  Drug Alcohol Depend       Date:  2014-02-12       Impact factor: 4.492

7.  Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.

Authors:  K S Sink; K N Segovia; J Sink; P A Randall; L E Collins; M Correa; E J Markus; V K Vemuri; A Makriyannis; J D Salamone
Journal:  Eur Neuropsychopharmacol       Date:  2009-12-16       Impact factor: 4.600

8.  Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.

Authors:  E S Onaivi; O Carpio; H Ishiguro; N Schanz; G R Uhl; R Benno
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 10.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.